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Abstract
IgG1 mAb solutions were prepared with and without sodium chloride and subjected to different
environmental stresses. Formation of aggregates and particles of varying size was monitored by a
combination of size exclusion chromatography (SEC), Nanosight Tracking Analysis (NTA),
Micro-flow Imaging (MFI), turbidity, and visual assessments. Stirring and heating induced the
highest concentration of particles. In general, the presence of NaCl enhanced this effect. The
morphology of the particles formed from mAb samples exposed to different stresses was analyzed
from TEM and MFI images. Shaking samples without NaCl generated the most fibrillar particles,
while stirring created largely spherical particles. The composition of the particles was evaluated
for covalent cross-linking by SDS-PAGE, overall secondary structure by FTIR microscopy, and
surface apolarity by extrinsic fluorescence spectroscopy. Freeze-thaw and shaking led to particles
containing protein with native-like secondary structure. Heating and stirring produced IgG1
containing aggregates and particles with some non-native disulfide crosslinks, varying levels of
intermolecular beta sheet content, and increased surface hydrophobicity. These results highlight
the importance of evaluating protein particle morphology and composition, in addition to particle
number and size distributions, to better understand the effect of solution conditions and
environmental stresses on the formation of protein particles in mAb solutions.
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INTRODUCTION
A current concern with the use of monoclonal antibody-based therapeutics is their tendency
to aggregate and form particles during long-term storage and/or during accidental exposure
to environmental stresses. The formation of aggregates and particles may lead to an increase
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in immune response 1-3 or a decrease in efficacy of the drug.2,4 Protein aggregation can
occur during many stages of production (purification, formulation, and filling), or during
long-term storage, shipping, and even administration to the patient.5 Therefore it is
important to better understand the reasons for aggregation and particle formation due to
different stresses and formulation conditions in order to develop strategies to minimize its
occurrence.
Aggregation and particle formation in therapeutic protein formulations can be caused by a
variety of environmental stresses or by formulation conditions such as concentration,6-8
solution pH,6,9,10 and the presence or absence of certain excipients.6,7,9 Freezing can not
only lead to changes in the formulation pH6,11,12 and concentration of proteins and
excipients,6 but also to the formation of ice/water interfaces6,13-15 where protein adsorption
can induce partial protein unfolding and subsequent aggregation.6,9,15-17 Proteins subjected
to heating undergo conformational changes that can lead to the formation of aggregates and
particles.9,18 Mechanical stresses may cause shear or interfacial effects in which the protein
adsorbs to the air-water interface, leading to structural alterations which can initiate
aggregation as well.9,16,19,20 Stirring and shaking are both mechanical stresses that can also
cause cavitation, local thermal effects, bubble entrapment, and transportation of the
aggregated protein from the air-water or air-container interface into the bulk
solution.6,21,2223
One major challenge in studying protein aggregation experimentally is that a wide variety of
analytical techniques are required to characterize the formation of protein aggregates and
particles over a broad size range (from few nanometer to hundreds of microns).24 In
addition, it is also important to have complimentary, orthogonal techniques for analyzing
aggregates of similar size ranges since results can differ based on the principles and setup of
each technique.6 In this work, we follow the previously proposed definitions of protein
aggregates, across the size ranges of few nanometers to 100s of microns. 25 In this case
study, size exclusion chromatography (SEC) is used to analyze smaller aggregates in the
size range of tens of nanometers. Although it is a powerful analytical tool for monitoring
small nanometer-sized soluble aggregates, upon injection of sample into the column,
aggregates can potentially dissociate upon mixing with mobile phase or adhere to the
column thereby requiring careful method development and use of orthogonal techniques.26
For sizing submicron particles (0.1 to 1 μm), Nanosight Tracking Analysis (NTA) is used
while for micron (1-100 μm) size particles, Microflow-Imaging technique (MFI) is
employed. NTA tracks and sizes individual particles (unlike its DLS counterpart), but has
limited sensitivity in detecting low numbers of submicron particles. In addition to sizing and
counting particles like light obscuration, MFI also has digital imaging capabilities that can
provide morphological information allowing differentiation between silicone and protein
particles. To detect visible particles larger than 100 μm, visual assessments are employed.
Turbidity is also used as a general method to monitor the formation of aggregates and
particles in solution across the various size ranges. Although visual inspection is a
commonly used technique, even under pre-defined conditions and with extensive analyst
training, results may vary between different analysts. Turbidity provides semi-quantitative
information for comparisons of the overall aggregation state of a sample, but it does not
provide information regarding the size or number of particles. Detailed discussions of the
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strengths and limitations of these analytical techniques are described more thoroughly
elsewhere.27,28
Recently, there has been an increased emphasis on characterizing the morphology and
composition of particles in addition to counting and sizing them.27 As a starting point for
this work, MFI analysis, in addition to sizing and counting of subvisible particles, is used for
morphological analysis by utilizing parameters such as aspect ratio and intensity of the
digital images.29,30 For visualization of small, nanometer-sized aggregates, transmission
electron microscopy (TEM) is used.31 SDS-PAGE is used to determine the extent of
covalent, disulfide linkages present in aggregates.32 Extrinsic fluorescence spectroscopy
with 8-anilino-1-naphthalene sulfonate (ANS) probe provides information concerning the
surface hydrophobicity of aggregates.33;34,35 FTIR provides insights into the secondary
structure of native protein and aggregates in solution,6,36-38 with the use of a FTIR
microscope allowing for selection of individual protein particles for secondary structure
analysis.29
This paper is a “protein particle formation” case study by utilizing a variety of analytical
techniques to examine the effect of four different environmental stresses (freeze-thaw,
shaking, stirring, and heating) and formulation composition (salt concentration) on the
number, size range morphology, and compositional nature of the IgG1 aggregates/particles
formed from stressing the mAb solutions. Additionally, a new data visualization method
consisting of radar plot analysis was used to better evaluate the effects of environmental
stress and salt concentration on particle size distributions as well as changes in certain
morphological parameters measured by MFI. The trends observed in terms of types and
amounts of particles formed under the different stress conditions are discussed, along with
some comparisons to previous studies with different monoclonal antibodies.
EXPERIMENTAL METHODS
Materials
Purified monoclonal human IgG1 (mAb) was obtained from Janssen Biotech (Radnor, PA)
at 40 mg/mL. The reagents and stir bars required for sample preparation were purchased
from Sigma Aldrich (St. Louis, MO), and Fisher Scientific (Pittsburgh, PA). The 3 mL vials
and rubber stoppers used to generate protein aggregates were purchased from West
Pharmaceuticals (Lionville, PA). For counting and sizing of aggregates (using SEC, NTA,
MFI, turbidity, visual assessments), the mAb was diluted to 1 mg/mL using 10 mM sodium
acetate buffer, pH 5 ± 150 mM NaCl.23 This condition was also used for morphological
analysis of particles by MFI. For structural and morphological analysis of the aggregates
(using TEM, MFI, SDS-PAGE, FTIR-Microscopy, ANS-Fluorescence), the mAb was
diluted to 1 mg/ml in 10 mM sodium acetate buffer, pH 5 containing 150 mM NaCl.
Generation of Aggregates
The 40 mg/mL IgG1 mAb solution was diluted to 1 mg/mL in 10 mM sodium acetate buffer,
pH 5 ± 150 mM NaCl and then subjected to a variety of accelerated stress conditions. These
conditions were selected to match pH solution conditions used previously with a different
set of IgG mAbs23,39 In each case, the buffer controls were stressed similarly to the protein
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samples and analyzed using various sizing, counting, and characterization techniques. Since
the buffer controls showed very low particle counts, the data were not included in the
figures. For freeze-thaw stress, the mAb was frozen and thawed one to three times (indicated
as cycles) at -80°C and room temperature, respectively (labeled FT-C1 and FT-C3). For
shaking stress, the mAb was agitated at 300 rpm (using an IKA AS260.1 shaking platform)
for 1-3 days (labeled shake-D1 and shake-D3). For stirring stress, the mAb was stirred at an
intermediate speed (setting 5) on a stirring plate (ThermoSci Pierce Reacti-Therm III
#18823 Heating/Stirring Module) using Flea Micro Teflon coated magnets (Fisher
Scientific) for 1-3 days (labeled stir-D1 and stir-D3). For thermal stress, the mAb was
incubated at 60°C in an incubator (Revco Ultima II) for 1-3 days (labeled heat-D1 and heat-
D3).
Size-Exclusion Chromatography
A Shimadzu Prominence HPLC system equipped with a diode-array detector was employed
with a Tosoh Bioscience TSK-Gel Bioassist G3SWXL (7.8 mm × 30.0 cm) PEEK column
and a corresponding PEEK Guard column (TSK Guard Column SWXL, 6.0 mm × 4.0 cm)
that were preconditioned with BSA as described previously.26 Molecular weight standards
(Biorad Laboratories; Hercules, CA) were run to test for efficiency of separation and
resolution. Both the column and guard column were equilibrated at 30°C for 1 hour using
the mobile phase comprised of 0.2 M sodium phosphate, pH 6.8 at a flow rate of 0.7 ml/min.
Aggregated samples were centrifuged at 16,000g (851 rotor on an IEC Micromax 3593) for
5 min and 10 μL of supernatant was injected for analysis and monitored simultaneously at
214 and 280 nm for each 30 min sample run.26 Multimers, dimers, monomer, and fragment
peaks were quantified using the LC Solutions data analysis software provided with the
instrument as described elsewhere.26
Nanoparticle Tracking Analysis (NTA)
Submicron (nanometer) sized particles were measured using a Nanosight LM-14
(Nanosight, Amesbury, UK) with a high resolution EMCCD camera. Stressed mAb
solutions were centrifuged at 16,000g for 5 min and 300 uL of the supernatants were
injected into the sample holder. The stirred (with and without NaCl) and heat stressed (with
NaCl only) samples were diluted by a factor of 100 prior to analysis. Three 30 s movies
were taken at ambient temperature for each sample at a viscosity of 0.95 cP. Data analysis
was completed using NTA 2.3 software (Nanosight) with the required camera level and gain
adjustments. Dilution factors were accounted for in the data analysis.
Micro-Flow Digital Imaging
Subvisible (micron sized) protein particles were analyzed and imaged using a MFI DPA
4200 (Protein Simple, Santa Clara, CA). Prior to each analysis, the instrument was primed
with purified water to obtain a particle-free baseline. Samples were gently swirled and 1 mL
of each sample was removed using a low protein-binding pipette tip and loaded into a
sample holder. Some of the samples (stir-D1 and D3 with and without NaCl; shake-D3 with
NaCl; and heat-D3 with NaCl) were diluted by a factor of 100 prior to being passed through
the instrument at a flow rate of 0.1m/min. The data were obtained as described previously by
Kumru et al.40
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Data Visualization with Radar Plots
To generate MFI particle size distribution radar plots, subvisible particle concentrations and
sizes for both unstressed and stressed samples were obtained from MFI’s MVAS 1.3
software. Similarly, MFI particle morphology radar charts were created using the average
mean intensity and aspect ratio values for each sample. All samples were run independently
three times (n=3). The data were pre-processed in Excel and two radar plots (one showing
average values and one showing variability in the runs) were generated using the
MiddaughSuite software created in our lab.41 The two radar charts were superimposed using
Adobe Photoshop CS6. See Kalonia et al. 2013 and Kim et al. 2012 for a more detailed
description of this data visualization methodology as applied to protein aggregation and
conformational stability data, respectively.41,42
SDS-PAGE
Samples were centrifuged at 16,000g for 5 min to separate the soluble fraction (supernatant)
from the insoluble fraction (pellet). Both fractions were dissolved in NuPAGE LDS sample
buffer (Life Technologies, Carlsbad, CA) with and without 50 mM DTT (BioRad) and
incubated at 80°C for 90 s. Approximately 10 μg of each sample was separated on a 3-8%
Tris-Acetate gel using Tris-Acetate running buffer (Life Technologies) for 65 min at 150V.
A Hi-Mark unstained molecular weight ladder was used as a reference (Life Technologies).
The starting protein concentration for the supernatant of one sample (stir-D3) was low so a
maximum of 20 μL was loaded. Protein bands were visualized by staining with Bio-Safe
Coomassie blue (BioRad).
Turbidity
A HACH 2100 AN turbidimeter was used to monitor the turbidity of each of the samples.
Prior to running the aggregated samples, NTU calibration standards were used to generate a
standard curve.
Transmission Electron Microscopy (TEM)
Carbon-coated grids were dipped into methylene chloride for 10 s to remove the top carbon
layer and were dried for a few minutes. The images were obtained by uranyl acetate staining
and by following the procedure by Kumru et al.40
Free Thiol Quantitation
Samples were centrifuged at 16,000g for 5 min to separate the soluble (supernatant) and the
insoluble (pellet) fractions. The pellet was dissolved in 6M guanidine hydrochloride (Fisher
Scientific). The amount of free thiol in the samples as well as in the appropriate controls was
measured using the protocol described in the Measure-iT Thiol Assay Kit (Molecular
Probes) with a SpectraMax MS plate reader (Molecular Devices; Sunnyvale, CA).
Extrinsic Fluorescence Spectroscopy
Samples were centrifuged at 16,000g for 5 min to separate the soluble and insoluble
fractions. The pellet was resuspended in 10 mM sodium acetate, 150mM NaCl, pH 5. The
protein concentration of each of these supernatant and pellet components was measured
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using a Nanodrop spectrometer (Thermo Scientific) with light scattering correction. The
samples were diluted to 0.1 mg/mL in 10 mM sodium acetate, 150 mM NaCl, pH 5. 8-
Anilinonaphthalene-1-sulfonate (ANS; Sigma-Aldrich, St. Louis, MO) was added and the
ANS fluorescence of the samples were recorded according to Kumru et al.40 The signal
from the buffer with equivalent amount of ANS was subtracted from all measurements.
Fourier Transform Infrared Microscopy
Five μm gold filters (Pall Corporation) were used for analyzing the aggregated samples.
Filters were equilibrated by washing with 0.1 M NaOH. The samples were then filtered,
washed with ultrapure water, and dried overnight. A Bruker Hyperion FTIR Microscope
with a 15X objective was used to image individual particles. Two-hundred-fifty-six scans
were recorded from 600-4000 cm-1 with a viewing area of about 100 μm × 100 μm. To
observe the maximum change in secondary structure due to heating, a 1 mg/mL sample in
acetate buffer (10 mM sodium acetate, 150 mM NaCl, pH 5) was heated for 20 min at 80°C.
This heated sample (labeled heated control) was also filtered onto the 5 μm gold filter and
dried overnight. OPUS (V6.5) software was used for baseline and atmospheric correction.
The second derivative spectra were obtained using a nine-point Savitzky-Golay smoothing
function.
Fourier Transform Infrared Spectroscopy
The unstressed mAb at 1 and 10 mg/mL in 10 mM sodium acetate, 150 mM NaCl, pH 5
were analyzed with a Bruker Tensor 27 FTIR Spectrometer and a Bio-ATR cell. Two-
hundred-fifty-six scans were recorded from 600-4000 cm-1 at a resolution of 4 cm-1. To
observe changes in secondary structure as a function of temperature, 256 scans of 10 mg/mL
of unstressed sample were heated from 10-87.5°C at 4 cm-1 resolution and 120 s
equilibration time with 2.5°C increments.
RESULTS
Counting and Sizing of Aggregates and Particles Formed under Accelerated Stress
Conditions
SEC (soluble aggregates, <100 nm)—To determine the amount of smaller (soluble)
nanometer aggregates, the stressed IgG1 mAb samples were centrifuged and the resulting
supernatants were analyzed by SEC. The amount of protein material that did not elute from
the SEC (referred to as insoluble aggregates) was indirectly determined by monitoring the
decrease in the total area of the chromatogram peaks between unstressed (D0) and the
stressed samples. The earliest eluted peak was labeled as multimer, the second peak as
dimer, the third and largest peak as monomer, and the final peak as fragment based on the
estimated molecular weights. In the absence of salt, heat stressed samples produced more
fragments, dimers, and insoluble aggregates compared to the unstressed sample (Fig. 1A, I).
Stirring formed more multimers and insoluble aggregates (Fig. 1G), while freeze-thaw
formed a very small amount of multimers and dimers (Fig. 1A), compared to the unstressed
sample. Shaking (Fig. 1E) did not show an increase in any species relative to the unstressed
sample. In the presence of 0.15M NaCl, protein was further destabilized and generally
resulted in the formation of more aggregates. Heat-stressed mAb in the presence of NaCl
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(Fig. 1J) showed more insoluble aggregates, a larger decrease in monomer, and an increase
in multimer compared to its NaCl-free counterpart, which showed some fragment formation
and lower levels of impurity (Fig. 1I). Stirring the mAb solution in the presence of salt
resulted in a large increase in insoluble aggregate and a concurrent decrease in monomer
content (Fig. 1G vs. H). Freeze-thaw and shaking did not show changes in any species, but
in the presence of NaCl, a slight increase in insoluble aggregate was observed (Fig 1D, 1F).
Nanoparticle Tracking Analysis (NTA) (50-1000 nm particles)—NTA was used to
assess the concentration and size distribution of nanometer sized particles (also referred to as
submicron particles) formed in stressed and unstressed samples. Stirring of the mAb solution
in the absence of NaCl (Fig. 2A and 2C) generated the largest number of nanometer sized
particles (between ~150-250 nm). In contrast, in the presence of salt, heating generated the
most nanometer sized particles (Fig. 2B and 2D). The concentration of nanometer particles
present in the unstressed controls was below the instrument’s quantitation limit (data not
shown).
MFI (2-100 μm particles)—Subvisible particle data (concentration and size range of
micron size particles) obtained from MFI measurements of stressed and unstressed samples
were visualized using radar plots (Fig. 3 and Supplemental Fig. S1). This novel data
visualization method for MFI data is described in detail elsewhere.42 As shown in the key to
Figure 3, the concentric circles represent concentration of particles, with the lowest
concentration (102) being the innermost circle, and highest concentration (>107) being the
outermost. The 5 corners of the polygon within the circles represent the particle size bins.
An increase in size of the polygon towards one corner represents an increase in
concentration of particles in that size bin (e.g., stretching of a corner from the innermost
concentric circle to the outermost circle in size bin number 3 indicates that there is an
increase in the ≥10<25 μm particles from 102 to >107 particles/mL).
As shown in Figure 3, the size and concentration of subvisible particles formed is highly
dependent on the type of stress. In the absence of NaCl, freeze-thaw and heat stressed mAb
samples showed the lowest concentration of particles even after 3 cycles/days of stress,
while shaking and stirring showed a higher concentration of particles. Stirring produced the
most subvisible particles, especially in the 2-25 μm size range. In the presence of NaCl, a
higher concentration of particles, especially in the 2-25 μm size range, was observed in all of
the stressed mAb samples. The heated mAb showed a large difference in both particle
number and size in the presence and absence of salt that increased from day 1 to day 3. A
large variability in the larger particles was observed (the lighter shading on the radar plots
reflects the standard deviation of the measurements). In general, shaking the mAb solution
containing NaCl generated the largest subvisible particles (2-50 μm) (Fig. 3). Particle counts
of controls were negligible.
Turbidity and Visual Assessment—Results of turbidity measurements and visual
observations of the stressed mAb solutions are shown in Table 1. In samples lacking NaCl,
agitation and stirring resulted in the highest number of >100 μm (referred to as visible
particles, VP), with stirring producing the greatest turbidity. No major NaCl effect was seen
for the freeze-thaw stress. Agitation, stirring, and heating stresses on the mAb formed more
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VP and higher turbidity in the presence of NaCl than in the absence of it. The highest
turbidity levels were measured for stir-D3 samples, followed by stir-D1, and heat-D3. In
addition, the presence of NaCl increased the turbidity for the heated (heat-D1 and heat-D3)
protein compared to the corresponding heat stressed mAb samples without NaCl. Shaken or
stirred mAb samples formed a large number of visible particles regardless of the presence or
absence of NaCl.
Structural Characterization of Aggregates and Particles
Particle Morphology—As an initial step in characterizing the nature and composition of
the particles formed under different stresses, MFI was used to elucidate morphological
information (intensity and aspect ratio parameters) of the subvisible particles generated after
three days of stress (Fig. 3 and Supplemental Fig. S1). Aspect ratio is a ratio of width of the
particle relative to the height and intensity is related to the particle absorption
characteristics. Data were visualized in the form of a radar plot (Fig. 4). Figure 4 shows the
different stresses applied to mAb solutions with and without NaCl on the x-axis and the MFI
morphology parameters, intensity and aspect ratio, on the y-axis. The top and bottom radar
charts describe the intensity and aspect ratio, respectively, of the particles as a function of
stress and solution condition. As shown in the key to Figure 4, the aspect ratio of the micron
particles varies from ~0.35 (elongated) to 0.85 (more circular) and the intensity from about
350 (opaque) to 850 (highly transparent) intensity level units (ILU). It should be emphasized
that the concentric circles here do not represent concentration, but rather a change in particle
morphology with the outermost circle representing elongated, opaque particles, and the
innermost circle representing transparent, circular particles. The corners of the 5-sided
polygon represent distinct particle size bins (labeled 1-5 in the figure). The pink-shaded
region indicates that an insufficient number of particles were collected in that size range for
accurate morphological analysis.
In the absence of NaCl, the shaking of the mAb solution over 3 days resulted in particles
that appeared transparent (Fig. 4A) and elongated (Fig. 4B) over all particle size ranges. In
the presence of NaCl under the same stress condition, the particles formed are less
transparent (i.e., more opaque) and less elongated (i.e., more circular in shape) over a
narrower size range. Stirring-induced mAb particles formed in the presence or absence of
NaCl do not show notable differences in intensity or aspect ratio. The concentration of
particles in the freeze-thaw and heated samples without NaCl was lower (Fig. 3) and an
accurate comparison of the morphology change across the size ranges was limited (as shown
by the shaded areas in Figure 4).
To characterize the morphology of smaller particles, TEM was used to examine the shape of
nanometer sized aggregates generated from 3 days of different stresses in the presence of
0.15 M NaCl. Some representative TEM images are shown in Figure 5. It can be seen that
the type of stress to which the mAb solution was subjected influences the morphology of the
aggregates generated. Freeze-thaw and heated aggregates appear very fibrillar, while
agitated-induced aggregates appear fibrillar with some spherical aggregates. The stirring-
induced aggregates were predominantly spherical in nature in this size range.
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Non-native disulphide cross-linking—SDS-PAGE was used to study the formation of
non-native covalent crosslinking in the stressed mAb. Results for the stirring and heating
stressed mAb containing NaCl are shown in Figure 6A and B (non-reduced and reduced,
respectively). These samples were first centrifuged to separate the supernatant (S) and pellet
components (P) prior to electrophoresis. The non-reduced supernatants contained
predominantly monomers while the pellets contained high molecular weight species above
500 kDa (i.e., larger than tetramer). Upon reduction of the supernatant and pellet, a complete
loss in the high molecular weight material was observed with the light and heavy chains
bands of the mAb visible as the primary species. The pellet for stir-D1 and D3, heat-D1 and
D3 contained significant amounts of non-native disulfide linked aggregates. The supernatant
of heat-D1 protein contained some of these non-native disulfide linked aggregates as well.
No disulfide-linked aggregates were detected in freeze-thaw and agitation stressed mAb
samples (data not shown). The number of free sulfhydryl groups in the mAb samples was
also measured, and virtually no free thiols were present in control or stressed samples (data
not shown).
Overall secondary structure content—The secondary structure of the aggregated
samples was studied using FTIR spectroscopy of control mAb samples and FTIR
microscopy of individual particles formed by stress in 10 mM acetate, 150 mM NaCl, pH 5.
Representative spectra are shown in Figure 7 along with wavelength values from multiple
measurements including standard deviations. Two mAb controls were prepared for
comparison to the particles formed from stressed samples: an unstressed mAb with native
conformation (Figure 7A in the form of second derivative FTIR spectra) and particles
isolated from an extensively heated mAb sample with some degree of structural
perturbations (Figure 7B). Figures C-F show microscopic images and the corresponding
FTIR spectra of isolated amorphous mAb particles generated under different stresses.
In the Amide I region of the second derivative FTIR spectra of the native mAb, two minima
at 1637 cm-1 and 1690 cm-1 were observed (Figure 7A). This result is consistent with the
predominantly intramolecular beta sheets present in native IgGs. 9,43,44 For the isolated
mAb particles from the extensively heat stressed control, severely altered secondary
structure displaying extensive loss of intramolecular beta sheet structure (as shown by loss
of the two minima seen in the native mAb control, and the appearance of intermolecular beta
sheets with minima at 1617 cm-1, and 1693 cm-1 (Figure 7B) is seen. For the isolated mAb
particles produced by three days of heating at 60°C, the spectra show the sample is more
similar to the extensively heated control as evidenced by the presence of the two minima at
1624 cm-1 and 1694 cm-1.45,46 The mAb particles isolated after three freeze-thaw cycles and
three days of agitation have FTIR spectra with primarily native-like structure as seen by the
second derivative minima at 1634 cm-1 and 1691 cm-1 and 1635 cm-1 and 1692 cm-1,
respectively. The stirred aggregates show reproducibly shifted minima in the main second
derivative peak to 1631 cm-1 indicating some alteration in secondary structure.
Surface hydrophobicity—To examine any changes in the exposure of apolar regions in
the stressed samples containing NaCl due to structural perturbations or aggregation/self-
association, ANS extrinsic fluorescence spectroscopy was used. Stress induced aggregated
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mAb samples were centrifuged and separated into supernatant and pellet components. They
were analyzed along with two controls: the unstressed mAb (D0) and a positive control
(Heat-melt). As a positive control to determine the greatest extent of apolar binding of ANS,
the mAb solution was heated from 10 to 87.5°C in the presence of ANS. From the emission
spectrum, it was determined that the maximum binding of ANS to the mAb occurred at
72°C suggesting maximal ANS access to apolar sites at high temperature. Representative
spectra are shown in Figure 8. The control mAb solution (D0) along with supernatants from
the FT, shake, and stir-D1 samples (Fig. 8A,B) show very little fluorescence intensity
indicating that in these samples, ANS has very little access to the apolar regions of the mAb.
In the stir-D1 pellet, slightly higher fluorescence intensity was observed, which suggests
some exposure of apolar sites in these aggregates (Fig. 8A, B). The heat-D1 supernatant and
pellet show the largest ANS fluorescence intensity increase suggesting the greatest exposure
of apolar regions. The heat stressed mAb samples containing NaCl displayed a similar
magnitude of fluorescence intensity as the positive control (heat-melt) indicating that this
stress condition may also generate samples with extensively apolar exposed regions.
DISCUSSION
As an initial set of experiments, we first counted and sized protein particles generated under
accelerated stress conditions employing an IgG1 mAb solution with and without 0.15 M
NaCl. A summary of the counting and sizing results from SEC, NTA, MFI, Turbidity, and
Visual Assessments are presented in Table 2. Different stresses (in the presence and absence
of NaCl) result in the formation of mAb aggregates and particles of varying sizes which
cannot be measured by a single analytical method. As shown in Table 2, using multiple
techniques is therefore very important for analyzing the formation of a broad size range of
aggregates. For example, SEC showed that the formation of soluble aggregates was
influenced by the presence of NaCl across the four stresses. NTA results demonstrated that
the presence of NaCl affected the extent of nanometer particle formation in the freeze-thaw
and heat stressed samples, but not for the agitated and stirred stressed samples. Similarly,
MFI detected that NaCl enhanced the formation of micron particles only for the freeze-thaw
stressed mAb sample. Finally, turbidity and visual assessments showed changes in particle
formation (due to the presence or absence of NaCl) with heat stressed mAb solutions.
Freeze-thaw stress was observed to be the mildest condition in solutions without NaCl since
essentially no detectable aggregates or particles were seen (Table 2, first row). Upon
addition of NaCl (Table 2, second row), some insoluble aggregates (detected as a loss of
total mass by SEC) and some nanometer and micron particles were detected by NTA and
MFI. Shaking the mAb solution with and without NaCl (third and fourth row in Table 2)
generated a turbid solution with primarily micron (2 to >100 μm) size particles observed by
MFI and visual inspection. The shaken solution in presence of NaCl was more turbid with
some insoluble aggregates, and a larger number of micron-sized particles 2 to >100 μm.
Stirring without NaCl produced a moderately turbid solution consisting of some insoluble
aggregates, submicron, micron, as well as a large number of visible entities. Stirring the
mAb solutions, in the presence of NaCl, generated the most turbid solutions consisting of a
very large amount of insoluble aggregates (20% after day 1 and around 60% after 3 days of
stress, as quantified by SE-HPLC). The largest differences in aggregate and particle
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formation were observed due to heating the mAb solution (Table 2; rows seven and eight).
Heating in the absence of NaCl generated a fairly clear solution consisting of primarily
monomers with a very small amount of insoluble aggregates and fragments (SEC), little to
no nanometer-sized (NTA), micron (MFI), and visible particles even after three days of
stress. In the presence of NaCl, however, a highly turbid solution formed containing much
more insoluble and multimer aggregates as well as a large increase in the number of
nanometer, micron, and visible sized particles.
Comparison of these results to other studies shows similar trends in which mAb aggregate
and particle formation depends on the type of stress and solution conditions. For an IgG1
mAb with a basic pI range formulated at lower solution pH such as pH 5.0, the addition of
NaCl (<0.15 M) may promote protein aggregation and particle formation during
environmental stress by a combination of effects resulting from neutralizing protein surface
charge and decreasing electrostatic interactions. These effects may promote protein-protein
interactions (colloidal stability) or decrease the structural integrity and stability of the
protein (conformational stability).9,47 The last column of Table 2 describes the impact of
NaCl on various stresses using eight analytical readouts obtained from four instruments. For
a given stress, column values can potentially range from 0/8, indicating NaCl had no impact
on the aggregation behavior, to 8/8 where NaCl impacted the aggregation behavior of the
mAb as measured by all of these analytical methods. Agitation and stirring stresses of the
mAb solution were least influenced by the presence of NaCl (1 out of 8). Although the two
stresses themselves were damaging to the protein, the addition of NaCl minimally increased
mAb instability (as manifested in detectable changes in SEC for percent insoluble aggregate
and monomer content for agitation and stirring stresses, respectively). Aggregation of the
mAb under freeze-thaw stress was more influenced by the presence of NaCl (3 out of 8).
Although freeze-thaw stress does not seem to cause alterations in the conformation of the
mAb (see below), increases in percent insoluble and soluble aggregate, as well as nanometer
and micron sized particles (by SEC, NTA, and MFI, respectively) were noted due to the
presence of NaCl, indicating decreased colloidal stability. Finally, heat stress showed the
largest effect of NaCl on mAb instability (6 out of 8). While heating of the mAb solution in
the absence of salt alters the conformational stability of the protein, it does not result in
extensive aggregate or particle formation. With the addition of NaCl, however, there is now
a large colloidal component to the mAb instability.
Despite the availability of new analytical methods to accurately and precisely count and size
protein particles in the submicron and subvisible size range,27,28,48-51 biophysical
characterization of the nature, composition and structural integrity of the protein within
these particles remains a major analytical challenge. The focus of this work was to
characterize aggregates and particles formed in an IgG1 mAb in the presence of 0.15M NaCl
as a function of various stresses (freeze-thaw, shaking, stirring and heating). The primary
goal was to characterize the morphology, structural integrity and composition of the IgG1
particles formed in 0.15M NaCl containing solutions by probing the extent of non-native
covalent cross-linking, changes in overall protein secondary structure, and alterations in
surface hydrophobicity within the particles as formed by each type of stress applied to the
mAb solutions. Additionally, we also evaluated the morphology of these particles by TEM
and by a newly developed approach from our laboratory to analyze MFI size distribution
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and morphological data using radar plots.42 These plots are commonly used to summarize
large sets of protein data from multiple biophysical techniques. Radar plots are used to better
visualize particle size distribution and morphological parameters of the particles.42
The freeze-thaw stress appeared to be mild and essentially did not change the overall higher
order structure or covalent crosslinking of the protein within the aggregates. Particles,
isolated onto a gold filter, showed no detectable alterations in overall secondary structure
relative to the native IgG sample, even after three freeze thaw cycles. The nanometer sized
aggregates appeared to have a fibrillar morphology by TEM. The micron sized particles
(10-50μm) were opaque (less transparent) and more elongated. Similarly, freeze-thaw
samples showed very low surface hydrophobicity almost equal to that of the native protein.
There appeared to be no covalent cross-linking present in the sample and no corresponding
higher molecular weight aggregates seen on SDS-PAGE gels (data not shown). Results
obtained from similar experiments by Joubert et al. as well as Barnard et al and Zhang et
al.52,53 with different mAbs were consistent with our observations.23
For mAb solutions stressed by shaking, a common stress encountered by many protein drugs
during transportation, generated predominantly fibrillar and slightly spherical nanometer
particles, while the micron sized particles were more opaque and circular than the samples
shaken without NaCl, as shown in Figures 4 and 5. These stressed samples contained little to
no covalently linked aggregates with largely native-like secondary structure and low surface
hydrophobicity (Figs 6-8) even after three days of shaking stress. While shaking generated
higher number of aggregates and particles than freeze-thaw, there were not many differences
in the biophysical characteristics of the aggregates generated by these two stresses compared
to the unstressed, native protein. This result is similar to data published previously with
other proteins.17,23,54
Stirring stress was a harsher condition on the IgG1 compared to freeze-thaw and shaking. In
addition, the particles generated from this stress were predominantly spherical in
morphology which was not observed with other stresses. From the MFI morphology data,
NaCl did not notably affect particle morphology (in terms of aspect ratio and intensity) of
the stirred samples in the micron size range as shown by the radar chart analysis in Figure 4.
Biophysical differences were also observed in protein from the pellet fraction and
supernatant fraction of the centrifuged stirred IgG mAb samples. The protein in the pellet
fraction displayed greater surface hydrophobicity (Figure 8) and contained an increased
amount of reducible high molecular weight covalently linked aggregates (Figure 6) than the
supernatant fraction. The ANS fluorescence data suggest that the population of aggregates
present in the pellet may be more structurally altered compared to the aggregates present in
the supernatant. The isolated stir-stressed particles showed some loss in overall
intramolecular beta sheet structure content and some increase in the formation of
intermolecular beta sheet structures (non-native, aggregated structures) as shown by FTIR
analysis (Figure 7). One study reported that the overall secondary structure of the stirred
sample was similar to that of the unstressed sample, contrary to our results with this IgG.17
In addition to rapid transportation of aggregates into bulk solution from the interface, protein
also encounters the harsh shear force of the stir-bar and the resulting thermal effects as well
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as cavitation.17,55 All of these factors could account for higher aggregation and particulation
with stirring stress compared to shaking.
For the heated samples of the IgG mAb, the supernatant fraction contained less non-native
covalently linked aggregates compared to the pellet fraction which possessed higher levels
of this type of disulfide cross-linked aggregate as measured by SDS-PAGE (Figure 6). The
variability in the micron particle concentration was very high due to heating, so it is difficult
to make definitive conclusions about the aspect ratio or intensity of these particles, although
more elongated and more opaque particles were seen in the presence of NaCl (Figure 4). In
the presence of NaCl, nanometer sized particles seen by TEM appeared fibrillar in
morphology (Figure 5). The heat stressed samples displayed a highly perturbed overall
secondary structure content consisting of predominantly intermolecular beta sheets as
measured by FTIR (Figure 7). The increased ANS binding in both the supernatant and pellet
of the centrifuged heated samples suggests significant exposure of apolar moieties in both
fractions. Hawe et al. noted that the heat generated aggregates contained non-native covalent
cross-linking with significantly increased ANS binding (increase in surface hydrophobicity),
as well as a large perturbation in the secondary structure 18,23 Zhang et al. conducted a
similar experiment with Bevacizumab and determined that heat generated aggregates had
significantly altered structure from their ANS and intrinsic Trp fluorescence data.53 These
results are consistent with our observations
In summary, while there has been a vast growth in our ability to count and size protein
aggregates and particles over a wide size range during the past ~5 years, our analytical
capabilities to describe the morphology, structural integrity and composition of the protein
within these particles is still limited. The goal of this study was to provide a case study to
examine the effect of different environmental stresses on an IgG1 mAb solution in terms of
the morphology of particles formed as well the extent of structural alterations of the protein
within the particles. We confirmed results of previous studies 17,18,23,52,55 that the type of
stress a mAb solution experiences greatly influences many of its physical properties in
distinct ways. There are still many gaps in our understanding that need to be addressed, 56
especially if there is a relationship between a particular particle count, particle size range,
particle weight or perhaps the physicochemical or morphological trait(s) of protein particles/
aggregates and their potential to generate an immune response in vivo. 56-62
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Formation of soluble and insoluble aggregates in IgG1 mAb solutions exposed to different
stresses as measured by SEC. (A, B) Representative SEC chromatograms monitored at 214
nm of 1 mg/mL antibody in 10 mM sodium acetate, pH 5 in absence (A) and presence (B) of
150 mM NaCl. Key: Day 0 Control (—), F/T Cycle 3 ( ), Agitation Day 3 ( ),
Stirring Day 3 ( ), Heating Day 3 ( ). Plots of monomer loss and changes in amounts
of impurities as a function of different stresses are shown: freeze-thaw cycles (C) without
NaCl and (D) with NaCl; days of agitation (E) without NaCl and (F) with NaCl; days of
stirring (G) without NaCl and (H) with NaCl; days of heating (I) without NaCl and (J) with
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NaCl. Key for C-J:  -% Monomer; Impurity:▬- % Insoluble; ▲- % Multimer; ▼ - %
Dimer; ◆- % Fragment. Each graph represents the average of three separate experiments
(n=3). Error bars represent the 95% confidence interval.
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Formation of submicron sized particles in IgG1 mAb solutions exposed to different stresses
as measured by NTA. Representative NTA data showing the formation of nanometer sized
particles due to four indicated stresses applied to 1 mg/mL antibody solution containing 10
mM sodium acetate, pH 5 in the (A) absence of NaCl and (B) in the presence of NaCl.
Concentration of nanometer sized protein particles formed due to each stress at day 1 (D1)
and (D3) in the presence and absence of NaCl (C, D). Each data point are the average of
three separate experiments (n=3) and the error bars for each data point represent the 95%
confidence interval.
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Radar plots for visualizing formation of subvisible particles (concentration and size
distributions) in IgG1 mAb solutions exposed to different stresses as measured by MFI.
Radar plots show MFI particle concentration and size data distributions as generated by four
indicated stresses when applied to 1 mg/mL antibody solution containing 10 mM sodium
acetate, pH 5 with and without 150 mM NaCl. See text for details of radar plot analysis. The
data shown are the average of three separate experiments (n=3) and the error represents the
95% confidence interval.
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Radar plots for visualizing morphology parameters of subvisible particles (aspect ratio and
intensity) in IgG1 mAb solutions exposed to different stresses as measured by MFI. Radar
plots show MFI morphology data distributions as generated by four indicated stresses when
applied to 1 mg/mL antibody solution containing 10 mM sodium acetate, pH 5 with and
without 150 mM NaCl. See text for details of radar plot analysis. The data shown are the
average of three separate experiments (n=3) and the error represents the 95% confidence
interval.
Telikepalli et al. Page 22























Representative TEM images of IgG1 mAb aggregates and particles formed after 3 freeze-
thaw cycles or three days of each indicated stress. Particles were isolated from 1 mg/mL
antibody solution in 10 mM sodium acetate, 150 mM NaCl, pH 5.
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Reduced and non-reduced SDS-PAGE gels of IgG1 mAb samples exposed to four different
stresses. Samples contained 1 mg/ml antibody in 10 mM sodium acetate, 150 mM NaCl, pH
5. High molecular weight aggregates formed by disulfide linkages were observed in pellet of
stir-Day 1, stir-Day 3, heat-Day 1 and heat-Day 3 samples. Stressed samples were
centrifuged to separate supernatant (S) from pellet (P), run on SDS-PAGE, and stained as
described in methods section.
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FTIR analysis of overall secondary structure of IgG mAb solutions and isolated particles as
generated from four indicated stresses. Samples contained 1 mg/ml antibody in 10 mM
sodium acetate, 150 mM NaCl, pH 5. Second derivative FTIR spectrum of (A) native,
unstressed protein in solution, and (B) mAb heated at 80°C for 20 min to determine the
maximum extent of secondary structure loss in solution, (C, D, E, F) Representative optical
images of isolated mAb particles (by passing through gold filter) as generated from the four
indicated stresses and their corresponding second derivative FTIR spectra from FTIR
microscope. Numerical values are the average of three separate experiments (n=3) with error
associated with the wavenumbers representing the 95% confidence interval.
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ANS extrinsic fluorescence analysis of IgG1 mAb samples (supernatant and pellet
components) before and after indicated stress was applied to samples. Samples contained 1
mg/ml mAb in 10 mM sodium acetate, 150 mM NaCl, pH 5. (A) Representative ANS
spectra, and (B) ANS fluorescence intensity values (at 480 nm) for each stressed mAb
sample compared to the two controls: unstressed (D0) and extensively heated samples
(Heat-melt). The average intensities shown are based on three separate experiments (n=3).
The error bars represent 95% confidence interval.
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